Some early stage spermatogonial tumors are potentially curable and have good therapeutic effect; patients with middle and late stage may be difficult to be cured, but the survival effect after active treatment is also good, and the five-year survival rate can reach more than 70%. Spermatogonial cell tumor is a kind of testicular tumor originated from germ cells, which mainly manifests as painless lump on one side of testis, and a small number of people will also have gynecomastia, syringomyelia and other manifestations, and distant metastasis may occur in the late stage. According to the specific conditions of the patient’s tumor, it can be divided into three stages: I, II and III, with different treatment effects in different stages. For stage I patients, at this time, seminomas are in early stage and often have no metastasis, simple surgical treatment may cure about 80% of patients, and if supplemented with chemotherapy, the cure rate can be increased to about 97%. For stage II patients, metastasis of retroperitoneal lymph nodes may occur. When the metastatic lymph nodes are not too big, chemotherapy and radiotherapy can achieve better curative effect, and the five-year survival rate of the patients may be about 90%~95%. For people with stage III disease, after distant metastasis occurs, the effect of treatment is related to the sensitivity of the individual, usually speaking, after regular treatment, the five-year survival rate of the intermediate and high-risk group of people is about 70%. It is recommended that patients with appropriate symptoms actively consult a doctor and undergo early treatment in order to improve the cure rate of the disease.